ArticlePloS one2020
Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective.
Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 14 citations in OpenAlex.
- Building on the Doha Declaration: a white paper on advancing lifestyle medicine for non-communicable disease prevention and health system transformation.Frontiers in public health · 2026Article
- Prevalence of mild cognitive impairment and its association with malnutrition in older Chinese adults in the community.Frontiers in public health · 2024Article
- The tide of dietary risks for noncommunicable diseases in Pacific Islands: an analysis of population NCD surveys.BMC public health · 2022Article
- Cognitive Frailty in Thai Community-Dwelling Elderly: Prevalence and Its Association with Malnutrition.Nutrients · 2021Article
- Differential Regulation of Interferon Signaling Pathways in CD4International journal of molecular sciences · 2021Article
- Nexus of COVID-19 and diabetes pandemics: Global public health lessons.Diabetes research and clinical practice · 2020Article
- Correction: Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective.PloS one · 2020Article
- CEvidence-based complementary and alternative medicine : eCAM · 2020Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Noncommunicable diseases (NCDs), such as heart disease, cancer, diabetes, and chronic respiratory disease, are responsible for seven out of every 10 deaths worldwide. While NCDs are associated with aging in high-income countries, this representation is often misleading. Over one-third of the 41 million annual deaths from NCDs occur prematurely, defined as under 70 years of age. Most of those deaths occur in low- and middle-income countries (LMICs) where surveillance, treatment, and care of NCDs are often inadequate. In addition to high health and social costs, the economic costs imposed by such high numbers of excess early deaths impede economic development and contribute to global and national inequity. In higher-income countries, NCDs and their risks continue to push health care costs higher. The burden of NCDs is strongly intertwined with economic conditions for good and for harm. Understanding the multiple ways they are connected-through risk factor exposures, access to quality health care, and financial protection among others-will determine which countries are able to improve the healthy longevity of their populations and slow growth in health expenditure particularly in the face of aging populations. The aim of this Special Collection is to provide new evidence to spur those actions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.